Publikationen (54) Publikationen, an denen Forscher/innen teilgenommen haben

2023

  1. Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 397-400

2022

  1. At-admission HbA1c levels in hospitalized COVID-19 participants with and without known diabetes

    Clinica Chimica Acta, Vol. 532, pp. 188-192

  2. Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis

    Pharmaceutics, Vol. 14, Núm. 8

  3. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1

  4. The oxyhaemoglobin dissociation curve is generally left-shifted in COVID-19 patients at admission to hospital, and this is associated with lower mortality

    British Journal of Haematology, Vol. 199, Núm. 3, pp. 332-338

2021

  1. A chitosan-based nanosystem as pneumococcal vaccine delivery platform

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 581-597

  2. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis

    Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 465-478

  3. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  4. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

  5. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities

    IUBMB Life, Vol. 73, Núm. 5, pp. 761-773

2020

  1. CD26-Related Serum Biomarkers: SCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context

    Disease Markers, Vol. 2020

  2. Immunology and immunotherapy of colorectal cancer

    Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (Springer), pp. 261-289

2019

  1. Design of polymeric nanocapsules to improve their lympho-targeting capacity

    Nanomedicine, Vol. 14, Núm. 23, pp. 3013-3033

  2. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  3. Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1023-1030

2018

  1. Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes

    Diabetes Research and Clinical Practice, Vol. 142, pp. 100-109

  2. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves’ disease patients

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 3, pp. 1538-1547

  3. IC-Tagging methodology applied to the expression of viral glycoproteins and the difficult-to-express membrane-bound IGRP autoantigen

    Scientific Reports, Vol. 8, Núm. 1

  4. Oral hygiene might prevent cancer

    Heliyon, Vol. 4, Núm. 10

2017

  1. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 903-910